{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:05:50Z","timestamp":1791907550598,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Clinical trials provided controversial results on whether the injection of hyaluronan preparations into osteoarthritic joints reduces pain. Problems of clinical studies may be the substantial placebo effects of intra-articular injections, different severity and rate of progression of the disease and others. We hypothesize that the use of preclinical pain models may help to clarify whether a certain hyaluronan exerts antinociceptive effects upon intra-articular injection. In the present study we tested in the bradykinin\/prostaglandin E<jats:sub>2<\/jats:sub>(PGE<jats:sub>2<\/jats:sub>) model primarily the putative antinociceptive effect of stabilized hyaluronic acid from a non animal source (NASHA), a stabilized hyaluronic acid based gel for intra-articular treatment of OA. We established a dose-response relationship for NASHA and we compared NASHA to other hyaluronans with different formulations that are in clinical use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To induce transient joint pain episodes bradykinin and PGE<jats:sub>2<\/jats:sub>were repetitively administered intra-articularly and unilaterally into rat knee joints during short anaesthesia. After establishment of the predrug nociceptive responses, a single intra-articular injection of saline or NASHA at different concentrations was administered and pain responses to further bradykinin\/PGE<jats:sub>2<\/jats:sub>injections were monitored up to 56 days after NASHA. Furthermore, the obtained effective dose was compared to clinically defined concentrations of Hylan GF20 and sodium hyaluronate. The primary outcome measures were primary mechanical hyperalgesia at the knee joint and pain-induced weight bearing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>On day 1 after injection, all tested hyaluronan preparations showed an antinociceptive effect &gt;50% compared to saline. Single injections of higher doses of NASHA (50, 75 and 100 \u03bcl) were antinociceptive up to 56 days. When injection volumes in rat knee joints were adapted to clinical injection volumes in humans, the antinociceptive effects of the cross-linked NASHA and Hylan GF20 had a longer duration than that of the non cross-linked sodium hyaluronate (with a slightly better effect of NASHA than Hylan GF20).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In the bradykinin\/PGE<jats:sub>2<\/jats:sub>model of joint pain a single injection of all hyaluronan preparations provided significant antinociceptive effects compared to saline. It appeared that the duration of the antinociceptive effect of the cross-linked hyaluronan preparations NASHA and Hylan GF20 was more prolonged. In addition, the gel beads structure allowing only a slow release of hyaluronic acid (NASHA) may even enhance this prolonged antinociceptive effect.<\/jats:p><\/jats:sec>","DOI":"10.1186\/ar3394","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T18:15:22Z","timestamp":1313086522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain"],"prefix":"10.1186","volume":"13","author":[{"given":"Michael Karl","family":"Boettger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"K\u00fcmmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"key":"3140_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","volume":"10","author":"H Breivik","year":"2006","unstructured":"Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D: Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006, 10: 287-333. 10.1016\/j.ejpain.2005.06.009.","journal-title":"Eur J Pain"},{"key":"3140_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0033-8389(03)00161-1","volume":"42","author":"DT Felson","year":"2004","unstructured":"Felson DT: An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 2004, 42: 1-9. 10.1016\/S0033-8389(03)00161-1.","journal-title":"Radiol Clin North Am"},{"key":"3140_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/art.1780300811","volume":"30","author":"DT Felson","year":"1987","unstructured":"Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF: The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987, 30: 914-918. 10.1002\/art.1780300811.","journal-title":"Arthritis Rheum"},{"key":"3140_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/art.1780290811","volume":"29","author":"SJ Dardick","year":"1986","unstructured":"Dardick SJ, Basbaum AI, Levine JD: The contribution of pain to disability in experimentally induced arthritis. Arthritis Rheum. 1986, 29: 1017-1022. 10.1002\/art.1780290811.","journal-title":"Arthritis Rheum"},{"key":"3140_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s001320170022","volume":"30","author":"J Steinmeyer","year":"2001","unstructured":"Steinmeyer J: Drug therapy of arthrosis. Orthop\u00e4de. 2001, 30: 856-865.","journal-title":"Orthop\u00e4de"},{"key":"3140_CR6","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1016\/S0002-9343(97)00204-0","volume":"104","author":"P Brooks","year":"1998","unstructured":"Brooks P: Use and benefits of nonsteroidal anti-inflammatory drugs. Am J Med. 1998, 104: 9S-13S. discussion 21S-22S","journal-title":"Am J Med"},{"key":"3140_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s00132-003-0559-2","volume":"32","author":"H Bauer","year":"2003","unstructured":"Bauer H, Marker-Hermann E: Therapy with nonsteroidal anti-inflammatory drugs. Orthop\u00e4de. 2003, 32: 1088-1094.","journal-title":"Orthop\u00e4de"},{"key":"3140_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1185\/03007999209115222","volume":"13","author":"G Grecomoro","year":"1992","unstructured":"Grecomoro G, Piccione F, Letizia G: Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Curr Med Res Opin. 1992, 13: 49-55. 10.1185\/03007999209115222.","journal-title":"Curr Med Res Opin"},{"key":"3140_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1063-4584(05)80018-4","volume":"3","author":"AC Jones","year":"1995","unstructured":"Jones AC, Pattrick M, Doherty S, Doherty M: Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage. 1995, 3: 269-273. 10.1016\/S1063-4584(05)80018-4.","journal-title":"Osteoarthritis Cartilage"},{"key":"3140_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ard.2008.094623","volume":"69","author":"X Chevalier","year":"2010","unstructured":"Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, Bailleul F, Pavelka K: Single, intraarticular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010, 69: 113-119. 10.1136\/ard.2008.094623.","journal-title":"Ann Rheum Dis"},{"key":"3140_CR11","first-page":"307","volume":"21","author":"DH Neustadt","year":"2003","unstructured":"Neustadt DH: Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol. 2003, 21: 307-311.","journal-title":"Clin Exp Rheumatol"},{"key":"3140_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/sarh.2002.50013","volume":"32","author":"G Kolarz","year":"2003","unstructured":"Kolarz G, Kotz R, Hochmayer I: Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum. 2003, 32: 310-319. 10.1053\/sarh.2002.50013.","journal-title":"Semin Arthritis Rheum"},{"key":"3140_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.joca.2004.04.010","volume":"12","author":"RD Altman","year":"2004","unstructured":"Altman RD, Akermark C, Beaulieu AD, Schnitzer T: Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004, 12: 642-649. 10.1016\/j.joca.2004.04.010.","journal-title":"Osteoarthritis Cartilage"},{"key":"3140_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/ard.2009.118042","volume":"69","author":"A Jorgensen","year":"2010","unstructured":"Jorgensen A, Stengaard-Pedersen K, Simonsen O, Pfeiffer-Jensen M, Eriksen C, Bliddal H, Pedersen NW, Bodtker S, Horslev-Peteren K, Snerum LO, Egund N, Frimer-Larsen H: Intra-articular hyaluronan is without clinical effect in knee osteoarthritis a multicentre, randomised, placebo-controlled, double-bling study of 337 patients followed for 1 year. Ann Rheum Dis. 2010, 69: 1097-1102.","journal-title":"Ann Rheum Dis"},{"key":"3140_CR15","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/ard.2008.092015","volume":"67","author":"W Zhang","year":"2008","unstructured":"Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M: The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008, 67: 1716-1723. 10.1136\/ard.2008.092015.","journal-title":"Ann Rheum Dis"},{"key":"3140_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1503\/cmaj.1041203","volume":"172","author":"J Arrich","year":"2005","unstructured":"Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, M\u00fcllner M: Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005, 172: 1039-1043. 10.1503\/cmaj.1041203.","journal-title":"CMAJ"},{"key":"3140_CR17","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1001\/jama.290.23.3115","volume":"290","author":"GH Lo","year":"2003","unstructured":"Lo GH, LaValley M, McAlindon , Felson DT: Intra-articular hyaluronic acid in treatment of knee osteoarthritis. JAMA. 2003, 290: 3115-3121. 10.1001\/jama.290.23.3115.","journal-title":"JAMA"},{"key":"3140_CR18","first-page":"CD005328","volume":"18","author":"N Bellamy","year":"2005","unstructured":"Bellamy N, Campbell J, Robinson V, Gee T, Boume R, Wells GA: Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2005, 18: CD005328-","journal-title":"Cochrane Database Syst Rev"},{"key":"3140_CR19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2460\/ajvr.1980.41.04.568","volume":"41","author":"JA Auer","year":"1980","unstructured":"Auer JA, Fackelman GE, Gingerich DA, Fetter AW: Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis. Am J Vet Res. 1980, 41: 568-574.","journal-title":"Am J Vet Res"},{"key":"3140_CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0034-5288(18)32580-3","volume":"30","author":"DA Gingerich","year":"1981","unstructured":"Gingerich DA, Auer JA, Fackelman GE: Effect of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: dosage titration studies. Res Vet Sci. 1981, 30: 192-197.","journal-title":"Res Vet Sci"},{"key":"3140_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/PL00005742","volume":"116","author":"MA Pozo","year":"1997","unstructured":"Pozo MA, Balazs EA, Belmonte C: Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res. 1997, 116: 3-9. 10.1007\/PL00005742.","journal-title":"Exp Brain Res"},{"key":"3140_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.11421","volume":"50","author":"A Gomis","year":"2004","unstructured":"Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C: Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthritis Rheum. 2004, 50: 314-326. 10.1002\/art.11421.","journal-title":"Arthritis Rheum"},{"key":"3140_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pain.2006.11.012","volume":"130","author":"A Gomis","year":"2007","unstructured":"Gomis A, Miralles A, Schmdit RF, Belmonte C: Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application. Pain. 2007, 130: 126-136. 10.1016\/j.pain.2006.11.012.","journal-title":"Pain"},{"key":"3140_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.joca.2008.11.013","volume":"17","author":"A Gomis","year":"2009","unstructured":"Gomis A, Miralles A, Schmidt RF, Belmonte C: Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig. Osteoarthritis Cartilage. 2009, 17: 798-804. 10.1016\/j.joca.2008.11.013.","journal-title":"Osteoarthritis Cartilage"},{"key":"3140_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/ard.52.11.817","volume":"52","author":"S Gotoh","year":"1993","unstructured":"Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, Tokuyasu K: Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993, 52: 817-822. 10.1136\/ard.52.11.817.","journal-title":"Ann Rheum Dis"},{"key":"3140_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0014-2999(97)00153-2","volume":"326","author":"CR Tonussi","year":"1997","unstructured":"Tonussi CR, Ferreira SH: Bradykinin-induced knee joint incapacitation involves bradykinin B2 receptor mediated hyperalgesia and bradykinin B1 receptor-mediated nociception. Eur J Pharmacol. 1997, 326: 61-65. 10.1016\/S0014-2999(97)00153-2.","journal-title":"Eur J Pharmacol"},{"key":"3140_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0304-3959(92)90095-S","volume":"48","author":"CR Tonussi","year":"1992","unstructured":"Tonussi CR, Ferreira SH: Rat knee-joint carrageenin incapacitation test: an objective screen for central and peripheral analgesics. Pain. 1992, 48: 421-427. 10.1016\/0304-3959(92)90095-S.","journal-title":"Pain"},{"key":"3140_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/0006-8993(88)90487-8","volume":"458","author":"YO Taiwo","year":"1988","unstructured":"Taiwo YO, Levine JD: Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. Brain Res. 1988, 458: 402-406. 10.1016\/0006-8993(88)90487-8.","journal-title":"Brain Res"},{"key":"3140_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(93)90183-P","volume":"55","author":"HG Schaible","year":"1993","unstructured":"Schaible HG, Grubb BD: Afferent and spinal mechanisms of joint pain. Pain. 1993, 55: 5-54. 10.1016\/0304-3959(93)90183-P.","journal-title":"Pain"},{"key":"3140_CR30","first-page":"3","volume-title":"Handb Exp Pharmacol","author":"HG Schaible","year":"2007","unstructured":"Schaible HG: Peripheral and central mechanisms of pain generation. Handb Exp Pharmacol. 2007, 3-28."},{"key":"3140_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.addr.2006.01.011","volume":"58","author":"HG Schaible","year":"2006","unstructured":"Schaible HG, Schmelz M, Tegeder I: Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev. 2006, 58: 323-342. 10.1016\/j.addr.2006.01.011.","journal-title":"Adv Drug Deliv Rev"},{"key":"3140_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1749-6632.2002.tb04234.x","volume":"966","author":"HG Schaible","year":"2002","unstructured":"Schaible HG, Ebersberger A, Von Banchet GS: Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002, 966: 343-354. 10.1111\/j.1749-6632.2002.tb04234.x.","journal-title":"Ann N Y Acad Sci"},{"key":"3140_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2165\/00003088-200241080-00004","volume":"41","author":"U Lindqvist","year":"2002","unstructured":"Lindqvist U, Tolmachev V, Kairemo K, Astrom G, Jonsson E, Lundqvist H: Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002, 41: 603-613. 10.2165\/00003088-200241080-00004.","journal-title":"Clin Pharmacokinet"},{"key":"3140_CR34","first-page":"1149","volume-title":"55th Annual Meeting of the Orthopedic Research Society","author":"K Edsman","year":"2009","unstructured":"Edsman K, Melin H, N\u00e4sstr\u00f6m J: A study of the ability of Durolane\u2122 to withstand degradation by free radicals while maintaining its viscoelastic properties. 55th Annual Meeting of the Orthopedic Research Society. 2009, Las Vegas: Congress Program; Itinerary Planner, 104: 1149-"},{"key":"3140_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00393-006-0063-2","volume":"65","author":"D Krocker","year":"2006","unstructured":"Krocker D, Matziolis G, Tuischer J, Funk J, Tohtz S, Buttgereit F, Perka C: Reduction of arthrosis associated knee pain through a single intra-articular injection of synthetic hyaluronic acid. Z Rheumatol. 2006, 65: 327-331. 10.1007\/s00393-006-0063-2.","journal-title":"Z Rheumatol"},{"key":"3140_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pain.2008.08.017","volume":"139","author":"AS Rice","year":"2008","unstructured":"Rice AS, Cimino-Brown D, Eisenach JC, Kontinen VK, Lacroix-Fralish ML, Machin I, Preclinical Pain Consortium, Mogil JS, St\u00f6hr T: Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain. 2008, 139: 243-247. 10.1016\/j.pain.2008.08.017.","journal-title":"Pain"},{"key":"3140_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF00370884","volume":"415","author":"V Neugebauer","year":"1989","unstructured":"Neugebauer V, Schaible HG, Schmidt RF: Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflugers Arch. 1989, 415: 330-335. 10.1007\/BF00370884.","journal-title":"Pflugers Arch"},{"key":"3140_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1113\/jphysiol.1988.sp017240","volume":"403","author":"HG Schaible","year":"1988","unstructured":"Schaible HG, Schmidt RF: Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol. 1988, 403: 91-104.","journal-title":"J Physiol"},{"key":"3140_CR39","first-page":"577","volume":"49","author":"T Omata","year":"1999","unstructured":"Omata T, Segawa Y, Itokazu Y, Inoue N, Tanaka Y: Effects of chondroitin sulfate-C on bradykinin-induced proteoglycan depletion in rats. Arzneimittelforschung. 1999, 49: 577-581.","journal-title":"Arzneimittelforschung"},{"key":"3140_CR40","first-page":"1793","volume":"27","author":"AJ Davis","year":"1994","unstructured":"Davis AJ, Kelly D, Perkins MN: The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli. Braz J Med Biol Res. 1994, 27: 1793-1802.","journal-title":"Braz J Med Biol Res"},{"key":"3140_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pain.2009.06.006","volume":"145","author":"MK Boettger","year":"2009","unstructured":"Boettger MK, Weber K, Schmidt M, Gajda M, Br\u00e4uer R, Schaible HG: Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain. 2009, 145: 142-150. 10.1016\/j.pain.2009.06.006.","journal-title":"Pain"},{"key":"3140_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.bjp.0705568","volume":"141","author":"GT Whiteside","year":"2004","unstructured":"Whiteside GT, Harrison J, Boulet J, Mark L, Pearson M, Gottshall S, Walker K: Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol. 2004, 141: 85-91. 10.1038\/sj.bjp.0705568.","journal-title":"Br J Pharmacol"},{"key":"3140_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1124\/jpet.103.050039","volume":"306","author":"G Villetti","year":"2003","unstructured":"Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, Pietra C, Rondelli I, Chamiot-Clerc P, Simonato M, Barbieri M: Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2003, 306: 804-814. 10.1124\/jpet.103.050039.","journal-title":"J Pharmacol Exp Ther"},{"key":"3140_CR44","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.23608","volume":"58","author":"MK Boettger","year":"2008","unstructured":"Boettger MK, Hensellek S, Richter F, Gajda M, St\u00f6ckigt R, Segond von Banchet G, Br\u00e4uer R, Schaible HG: Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum. 2008, 58: 2368-2378. 10.1002\/art.23608.","journal-title":"Arthritis Rheum"},{"key":"3140_CR45","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1152\/jn.1993.70.4.1365","volume":"70","author":"V Neugebauer","year":"1993","unstructured":"Neugebauer V, Lucke T, Schaible HG: N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol. 1993, 70: 1365-1377.","journal-title":"J Neurophysiol"},{"key":"3140_CR46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bbi.2009.12.002","volume":"24","author":"MK Boettger","year":"2010","unstructured":"Boettger MK, Weber K, Gajda M, Br\u00e4uer R, Schaible HG: Spinally applied ketamine or morphine attenuate peripheral inflammation and hyperalgesia in acute and chronic phases of experimental arthritis. Brain Behav Immun. 2010, 24: 474-485. 10.1016\/j.bbi.2009.12.002.","journal-title":"Brain Behav Immun"},{"key":"3140_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.1780100407","volume":"10","author":"EA Balazs","year":"1967","unstructured":"Balazs EA, Watson D, Duff IF, Roseman S: Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 1967, 10: 357-376. 10.1002\/art.1780100407.","journal-title":"Arthritis Rheum"},{"key":"3140_CR48","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1042\/bj2140777","volume":"214","author":"Y Sommarin","year":"1983","unstructured":"Sommarin Y, Heinegard D: Specific interaction between cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface. Biochem J. 1983, 214: 777-784.","journal-title":"Biochem J"},{"key":"3140_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF00270463","volume":"7","author":"MM Smith","year":"1987","unstructured":"Smith MM, Ghosh P: The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int. 1987, 7: 113-122. 10.1007\/BF00270463.","journal-title":"Rheumatol Int"},{"key":"3140_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.addr.2006.01.018","volume":"58","author":"N Gerwin","year":"2006","unstructured":"Gerwin N, Hops C, Lucke A: Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006, 58: 226-242. 10.1016\/j.addr.2006.01.018.","journal-title":"Adv Drug Deliv Rev"},{"key":"3140_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1113\/expphysiol.1991.sp003474","volume":"76","author":"TJ Brown","year":"1991","unstructured":"Brown TJ, Laurent UB, Fraser JR: Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol. 1991, 76: 125-134.","journal-title":"Exp Physiol"},{"issue":"Supplement","key":"3140_CR52","doi-asserted-by":"publisher","first-page":"C64","DOI":"10.1016\/S1063-4584(07)61732-4","volume":"15","author":"NE Larsen","year":"2007","unstructured":"Larsen NE, Dursema H, Skrabut EM: Clearance kinetics of a single injection crosslinked hylan-based viscosupplement in a rabbit model. Osteoarthritis Cartilage. 2007, 15 (Supplement): C64-","journal-title":"Osteoarthritis Cartilage"},{"key":"3140_CR53","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","volume":"7","author":"HB Van der Worp","year":"2010","unstructured":"Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR: Can animal models of disease reliably inform human studies?. PLoS Med. 2010, 7: e1000245-10.1371\/journal.pmed.1000245.","journal-title":"PLoS Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3394\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:00:02Z","timestamp":1741446002000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,8]]}},"alternative-id":["3140"],"URL":"https:\/\/doi.org\/10.1186\/ar3394","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]},"assertion":[{"value":"20 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R110"}}